You may know of us as a manufacturer and distributor and of IVD products, but did you know that we are also a biotechnology company?
BMD can place its know-how and expertise at the service of pharmaceutical or biotechnology firms for the development of customised tests.
Our expertise with state-of-the-art technologies enables us to support research and be a quality partner in developing tests and enhancing the discovery of new biomarkers.
Biomarkers are now essential tools in the discovery and evaluation of new therapeutic products and open up new prospects for the entire medical sector.
Whether they are used to predict the development of a disease, determine the progression of a condition or evaluate a patient's response to a treatment, biomarkers offer new possibilities for both the pharmaceutical industry and patients. In fact they can help reduce costs and improve the targeting of medication according to the patient's response to a treatment.
The global IVD market was valued at $5.4 billion in 2005 and it is estimated that it will quadruple by 2012 to $21.2 billion.*
As a biotechnology company, BMD can support you in the development of these biomarkers. Our know-how, recognised by major private and state laboratories, the quality of our industrial resources and that of our team of researchers as well as our flexibility, are all assets to help you enhance your research quickly and effectively.
